These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1427652)

  • 1. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
    Fattovich G; Giustina G; Brollo L; Guido M; Pontisso P; Noventa F; Alberti A
    Hepatology; 1992 Nov; 16(5):1115-9. PubMed ID: 1427652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole and interferon in children with chronic hepatitis B.
    Ruiz-Moreno M; García R; Rua MJ; Serrano B; Moraleda G; Feijoo E; Bartolomé J; Ortiz F; Castillo I; Carreño V
    Hepatology; 1993 Aug; 18(2):264-9. PubMed ID: 7687978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of ribavirin and interferon-beta for chronic hepatitis B.
    Kakumu S; Yoshioka K; Wakita T; Ishikawa T; Takayanagi M; Higashi Y
    Hepatology; 1993 Aug; 18(2):258-63. PubMed ID: 8340055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
    Akarca US; Ersoz G; Gunsar F; Karasu Z; Saritas E; Yuce G; Batur Y
    Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
    Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH; Deng X; Chen XC; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
    Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
    Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
    Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
    Sarin SK; Kumar M; Hissar S; Sharma BC
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
    van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
    J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].
    Deng H; Zhao ZX; Xu QH; Zhou YP; Chen YM; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):305-8. PubMed ID: 12773249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.